Showing results (191-200 of 252) with videos related to

Sort By:
Pageof 26
British Journal of Haematology|March 4, 2014
Everolimus for patients with mantle cell lymphoma refractory to or intolerant of bortezomib: multicentre, single-arm, phase 2 studyMichael Wang, Leslie L Popplewell, Robert H Collins, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 1, 2019
Phase I Study of the Novel Enhancer of Zeste Homolog 2 (EZH2) Inhibitor GSK2816126 in Patients with Advanced Hematologic and Solid TumorsTimothy A Yap, Jane N Winter, Lisa Giulino-Roth, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 21, 2010
Multicenter analysis of 80 solid organ transplantation recipients with post-transplantation lymphoproliferative disease: outcomes and prognostic factors in the modern eraAndrew M Evens, Kevin A David, Irene Helenowski, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 15, 2013
An individual patient-data comparison of combined modality therapy and ABVD alone for patients with limited-stage Hodgkin lymphomaA E Hay, B Klimm, B E Chen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 8, 2010
Expression of p21 protein predicts clinical outcome in DLBCL patients older than 60 years treated with R-CHOP but not CHOP: a prospective ECOG and Southwest Oncology Group correlative study on E4494Jane N Winter, Shuli Li, Vikas Aurora, et al.
Blood|November 23, 2013
An enhanced International Prognostic Index (NCCN-IPI) for patients with diffuse large B-cell lymphoma treated in the rituximab eraZheng Zhou, Laurie H Sehn, Alfred W Rademaker, et al.
Cancer|March 21, 2014
Prevalence and clinical implications of cyclin D1 expression in diffuse large B-cell lymphoma (DLBCL) treated with immunochemotherapy: a report from the International DLBCL Rituximab-CHOP Consortium ProgramChi Young Ok, Zijun Y Xu-Monette, Alexandar Tzankov, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 3, 2011
Vaccination with patient-specific tumor-derived antigen in first remission improves disease-free survival in follicular lymphomaStephen J Schuster, Sattva S Neelapu, Barry L Gause, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 17, 2008
Bcl-B expression in human epithelial and nonepithelial malignanciesMaryla Krajewska, Shinichi Kitada, Jane N Winter, et al.
Leukemia & Lymphoma|January 11, 2019
Autologous transplantation as consolidation for high risk aggressive T-cell non-Hodgkin lymphoma: a SWOG 9704 intergroup trial subgroup analysisZeina Al-Mansour, Hongli Li, James R Cook, et al.
Pageof 26